We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$7.91B
AUM Growth
-$1.76B
Cap. Flow
-$1.37B
Cap. Flow %
-17.29%
Top 10 Hldgs %
11.41%
Holding
2,902
New
788
Increased
705
Reduced
576
Closed
758

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$52.3M
2
EXC icon
Exelon
EXC
+$51.9M
3
LIN icon
Linde
LIN
+$48.3M
4
AMD icon
Advanced Micro Devices
AMD
+$41.5M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$39.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$251M
2
MSFT icon
Microsoft
MSFT
+$235M
3
AMZN icon
Amazon
AMZN
+$226M
4
CSGP icon
CoStar Group
CSGP
+$103M
5
AER icon
AerCap
AER
+$82.2M

Sector Composition

Rank Sector Weight
1 Technology 13.96%
2 Industrials 12.92%
3 Consumer Discretionary 9.79%
4 Financials 9.27%
5 Energy 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLR
2151
Allarity Therapeutics
ALLR
$22.1M
– –
0
– -$269K
ALNY icon
2152
Alnylam Pharmaceuticals
ALNY
$31.6B
– –
-5,745
Closed -$974K
ALV icon
2153
Autoliv
ALV
$9.02B
– –
-24,700
Closed -$2.55M
AMC icon
2154
AMC Entertainment Holdings
AMC
$2.38B
– –
-4,979
Closed -$1.35M
AMCX icon
2155
AMC Global Media
AMCX
$512M
– –
-30,260
Closed -$1.04M
AMCR icon
2156
Amcor
AMCR
$22.2B
– –
-32,354
Closed -$1.94M
AMN icon
2157
AMN Healthcare
AMN
$1.34B
– –
-12,501
Closed -$1.53M
AMP icon
2158
Ameriprise Financial
AMP
$49.6B
– –
-1,295
Closed -$391K
AMPY icon
2159
Amplify Energy
AMPY
$198M
– –
-12,666
Closed -$39K
AMRX icon
2160
Amneal Pharmaceuticals
AMRX
$6.19B
– –
-23,292
Closed -$112K
AMZN icon
2161
PUT
Amazon
AMZN
$2.83T
– –
-1,500,000
Closed -$250M
ANIX icon
2162
Anixa Biosciences
ANIX
$123M
– –
-10,029
Closed -$30K
AON icon
2163
Aon
AON
$76.2B
– –
-37,510
Closed -$11.3M
APD icon
2164
Air Products & Chemicals
APD
$68.2B
– –
-6,320
Closed -$1.92M
APEI icon
2165
American Public Education
APEI
$846M
– –
-9,391
Closed -$209K
API
2166
Agora
API
$358M
– –
-13,722
Closed -$222K
APLS
2167
DELISTED
Apellis Pharmaceuticals
APLS
– –
-13,939
Closed -$659K
APO icon
2168
Apollo Global Management
APO
$78.4B
– –
-36,792
Closed -$2.67M
APRE icon
2169
Aprea Therapeutics
APRE
$10.1M
– –
-866
Closed -$50K
AQB icon
2170
AquaBounty Technologies
AQB
$6.74M
– –
-1,346
Closed -$57K
AQN icon
2171
Algonquin Power & Utilities
AQN
$4.38B
– –
-28,967
Closed -$419K
ARCO icon
2172
Arcos Dorados Holdings
ARCO
$1.7B
– –
-40,957
Closed -$239K
ARDX icon
2173
Ardelyx
ARDX
$966M
– –
-39,136
Closed -$43K
ASH icon
2174
Ashland
ASH
$3.38B
– –
-4,166
Closed -$449K
ASLE icon
2175
AerSale
ASLE
$268M
– –
-18,547
Closed -$329K
85 86
87
88 89

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q1 2022 Portfolio in Review

As of Q1 2022, Michael Gelband held 2,902 positions worth $7.91B, down 18% from $9.67B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Michael Gelband withdrew a net $1.37B in Q1 2022, closing 758 positions and reducing 576 holdings. Its most notable exit was CoStar Group, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Michael Gelband opened a new position in Linde worth $49.9M.

  • Michael Gelband's largest Q1 2022 buy was Linde: 156,289 shares worth $49.9M.
  • Michael Gelband added most to ExxonMobil in Q1 2022, an estimated $52.3M increase.
  • Michael Gelband's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $251M.
  • Michael Gelband fully exited CoStar Group in Q1 2022, selling an estimated $103M.
  • Michael Gelband's ten largest holdings make up 11% of its $7.91B portfolio in Q1 2022.
  • Michael Gelband opened 788 new positions and closed 758 in Q1 2022.
  • Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.91B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.